ChromaDex Corp. (CDXC)

[bulldurham]

they expect the results from the human study in sept or oct...here is what Dr. Bartos said...

The solubility of a given polyhenol is an obvious defining characteristic for beverage makers. Jeremy Bartos, Ph.D., ingredient product manager for Chromadex, which offers the polyphenol pterostilbene as PteroPure®, said since pterostilbene is lipophilic (fat-soluble), beverage customers have been asking for a water-soluble version of pterostilbene. “We are currently working with partners to create a water-soluble version,” he noted, advising in the interim, those interested in using pTeroPure in a beverage are including it in premixes and drink powders. “With the small dose required for clinical efficacy, even if pterostilbene is not suspended in liquid, it will not be an issue with palatability or with intake.”

Food and beverage formulations have a longer timeline than supplements, but the market should see a significant uptake in these products in first quarter 2013 and beyond, according to Bartos. He said skin care is another area that will see significant growth in the next 12 to 18 months. “Because of its lipophilic nature, pterostilbene works well in oil-based lotions and creams and also absorbs nicely and directly into the skin,” he explained. “Expect to see an uptick in the cosmeceutical and even sun care industries in the next few years.” Animal health industry, especially in the equine market, is another emerging channel.

Bartos said pterostilbene is already available in capsules, tablets, drink powders, granola bars, cookies, popcorn and fast melts, but such lipophilic polyphenols are ideal for softgel formulation, a delivery form he is surprised hasn’t been utilized for pterostilbene. “And its heart-health benefits makes it a perfect partner for a fish oil formulation,” he said. “With the efficacy results of the first human clinical trial on pterostilbene slated for sometime in September or October, I wouldn’t be surprised to see this come to fruition sooner rather than later.”